These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36069086)

  • 21. Surgical Treatment of Dysthyroid Optic Neuropathy: Long-Term Visual Outcomes with Comparison of 2-Wall versus 3-Wall Orbital Decompression.
    Korkmaz S; Konuk O
    Curr Eye Res; 2016; 41(2):159-64. PubMed ID: 25835051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of medical and surgical decompression in patients with dysthyroid optic neuropathy.
    Garip Kuebler A; Wiecha C; Reznicek L; Klingenstein A; Halfter K; Priglinger S; Hintschich C
    Eye (Lond); 2020 Sep; 34(9):1702-1709. PubMed ID: 32366997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of orbital decompression on dysthyroid optic neuropathy: A retrospective case series.
    Liang QW; Yang H; Luo W; He JF; Du Y
    Medicine (Baltimore); 2019 Jan; 98(3):e14162. PubMed ID: 30653159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic difference between orbital decompression and glucocorticoids administration as the first-line treatment for dysthyroid optic neuropathy: a systematic review.
    Xu MN; Pan ZQ; Tu YH; Tao HQ; Shi KS; Wu WC
    Int J Ophthalmol; 2021; 14(7):1107-1113. PubMed ID: 34282398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visual function changes of dysthyroid optic neuropathy and ROC curve analysis for early diagnostic indicators.
    Wang S; Wang J; Chen L; Tan J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 48(8):1197-1202. PubMed ID: 37875359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dysthyroid optic neuropathy: surgical treatment potential].
    Grusha YO; Ismailova DS; Kochetkov PA; Andreeva NA
    Vestn Oftalmol; 2020; 136(4. Vyp. 2):193-200. PubMed ID: 32880139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urgent endoscopic orbital decompression for vision deterioration in dysthyroid optic neuropathy.
    Sowerby LJ; Rajakumar C; Allen L; Rotenberg BW
    Eur Ann Otorhinolaryngol Head Neck Dis; 2019 Jun; 136(3S):S49-S52. PubMed ID: 30170970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of intravenous high-dose glucocorticoids and orbital decompression surgery on sight-threatening thyroid-associated ophthalmopathy.
    Wen Y; Yan JH
    Int J Ophthalmol; 2019; 12(11):1737-1745. PubMed ID: 31741863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of Rituximab After Orbital Decompression Surgery in Two Grave's Ophthalmopathy Patients Progressing to Optic Neuropathy.
    Zhang B; Li Y; Xu W; Peng B; Yuan G
    Front Endocrinol (Lausanne); 2020; 11():583565. PubMed ID: 33193097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy of transethmoidal orbital decompression in patients with dysthyroid optic neuropathy].
    Grusha YO; Kochetkov PA; Ismailova DS; Svistushkin VM; Zhorzholadze NV; Spychak VY
    Vestn Otorinolaringol; 2020; 85(6):52-55. PubMed ID: 33474918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative clinical factors and visual outcomes following orbital decompression with dysthyroid optic neuropathy.
    Tagami M; Honda S; Azumi A
    BMC Ophthalmol; 2020 Jan; 20(1):30. PubMed ID: 31952487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective endoscopic decompression of the orbital apex for dysthyroid optic neuropathy.
    Chu EA; Miller NR; Lane AP
    Laryngoscope; 2009 Jun; 119(6):1236-40. PubMed ID: 19418538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical profile and visual outcomes after treatment in patients with dysthyroid optic neuropathy.
    Jeon C; Shin JH; Woo KI; Kim YD
    Korean J Ophthalmol; 2012 Apr; 26(2):73-9. PubMed ID: 22511831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of orbital morphology on proptosis reduction and ocular motility after decompression surgery in patients with Graves' orbitopathy.
    Oeverhaus M; Copei A; Mattheis S; Ringelstein A; Tiemessen M; Esser J; Eckstein A; Stähr K
    PLoS One; 2019; 14(6):e0218701. PubMed ID: 31233522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pterional Orbit Decompression in Grave Disease with Dysthyroid Optic Neuropathy.
    Kuechlin S; Steiert C; Naseri Y; Joachimsen L; Gruber M; Reich M; Boehringer D; Metzger M; Beck J; Scheiwe C; Lagrèze WA; Grauvogel J
    World Neurosurg; 2021 May; 149():e1007-e1016. PubMed ID: 33476778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy.
    Miśkiewicz P; Rutkowska B; Jabłońska A; Krzeski A; Trautsolt-Jeziorska K; Kęcik D; Milczarek-Banach J; Pirko-Kotela K; Samsel A; Bednarczuk T
    Endokrynol Pol; 2016; 67(2):166-73. PubMed ID: 26884288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of endoscopic orbital decompression for graves' ophthalmopathy.
    Woods RSR; Pilson Q; Kharytaniuk N; Cassidy L; Khan R; Timon CVI
    Ir J Med Sci; 2020 Feb; 189(1):177-183. PubMed ID: 31203506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of visual evoked potentials in dysthyroid optic neuropathy.
    Garip Kübler A; Halfter K; Reznicek L; Klingenstein A; Priglinger S; Rudolph G; Hintschich C
    Orbit; 2023 Oct; 42(5):475-480. PubMed ID: 36128945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-World Experience With Teprotumumab in Patients With Dysthyroid Optic Neuropathy.
    Tamhankar MA; Pradeep T; Chen Y; Briceño CA
    J Neuroophthalmol; 2024 Mar; 44(1):74-79. PubMed ID: 37751310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Customized Orbital Decompression Surgery Combined with Eyelid Surgery or Strabismus Surgery in Mild to Moderate Thyroid-associated Ophthalmopathy.
    Choi SW; Lee JY; Lew H
    Korean J Ophthalmol; 2016 Feb; 30(1):1-9. PubMed ID: 26865797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.